Multimodal Imaging in Retinal Disease: A Consensus Definition.

Advances in retinal imaging are fundamental to the recent paradigm shifts in the diagnosis and management of ocular disease and in the understanding of the pathogenesis of these disorders.1 Evaluation of a broad spectrum of various types of retinal images is essential to modern ophthalmic practice and has become the optimal standard of care for successful management of retinal disorders. There are a wide range of retinal technologies that can acquire two-dimensional or threedimensional en face and cross-sectional images, some of which are depth-resolved, that may provide information about anatomic structure, function, or dynamic vascular flow. Common imaging modalities include color fundus photography; near-infrared reflectance (NIR); fundus autofluorescence;2,3 fluorescein angiography; indocyanine green angiography;4 scanning-laser ophthalmoscopy with2,5 and without adaptive optics;6,7 optical coherence tomography (OCT);8-10 and, more recently, OCT angiography (OCTA).11,12 Each modality has unique advantages and limitations and requires a specific skill set for optimal application and interpretation. When analyzed together, different imaging modalities can increase diagnostic sensitivity and specificity. Recently, the term “multimodal imaging” has been used in an increasing number of clinical reports, emphasizing the importance of combining a variety of imaging modalities. However, no specific definition of this terminology has been established in ophthalmology. The term multimodal imaging has been used in a variety of medical specialties such as oncology,13 radiology14,15, and cardiology long before expansion of the term to describe ophthalmic imaging techniques. It has been defined as the combination of imaging modalities to provide improved preclinical assessment, diagnostics, and therapeutic monitoring.16 The Cardiology Imaging Council defined multimodal imaging as “the efficient integration of two or more methods of imaging to improve the ability to diagnose, guide therapy, or predict outcomes.”17 In ophthalmology, it is uncommon for clinicians to rely on a single imaging modality to determine diagnosis and therapy. Instead most choose more than one technique for a given clinical situation. To be successful, one must have knowledge of the potential benefits and shortcomings of each imaging modality to know which is ideal for any given clinical situation. Because there is considerable overlap in the information provided by certain imaging modalities, it is important for clinicians to choose the minimum numbers of studies needed to accomplish the clinical goal and to avoid unnecessary cost and burden to the patient. In ophthalmology, most reports classify multimodal imaging as the combination of en face fundus imaging, en face dye-base angiography, cross-sectional and/or en face OCT, and possibly autofluorescence when relevant to evaluate a specific disease.18-22 Analyzing images from multiple imaging modalities can be used as a preliminary step in understanding new technologies, such as when comparing dye-based angiography to OCTA.23 We propose a definition of multimodal imaging as it applies to the practice of ophthalmology: To comprise the use of more than one technological system to acquire images, concurrently or at a short period of time, that complement one another for the purpose of diagnosis, prognostication, management, and monitoring of disease. Thus, all modalities can analyze a specific structure unequivocally. This may include hybrid devices that can simultaneously perform more than one imaging modality. For example, a fundus camera may provide color images of the retina; however, if excitation and emission filters are added to the camera to obtain fundus autofluorescence imaging, this device could be considered a multimodal platform. Similarly, commercial systems that combine OCTA with a corresponding structural OCT B-scan of the retina utilize different technological platforms and provide contrasting anatomical (blood flow versus static tissue layers) information and could also be considered a multimodal approach. Therefore, when the retina is imaged by different technological systems (whether the machine is changed or not), providing a different image of the fundus, this would constitute, in the authors’ consensus, a multimodal-imaging platform. There are many clinical situations in which the application of a multimodal approach can enhance the evaluation and understanding of retinal disease.

[1]  S. Sadda,et al.  A Promising Future for Optical Coherence Tomography Angiography. , 2015, JAMA ophthalmology.

[2]  Jason Hsu,et al.  En Face Optical Coherence Tomography Imaging of Deep Capillary Plexus Abnormalities in Paracentral Acute Middle Maculopathy. , 2015, Ophthalmic surgery, lasers & imaging retina.

[3]  D. Sarraf,et al.  OCT Angiography of Paracentral Acute Middle Maculopathy Associated With Central Retinal Artery Occlusion and Deep Capillary Ischemia. , 2015, Ophthalmic surgery, lasers & imaging retina.

[4]  L. Sakata,et al.  Optical coherence tomography of the retina and optic nerve – a review , 2009, Clinical & experimental ophthalmology.

[5]  Bernd J Pichler,et al.  Multimodal imaging approaches: PET/CT and PET/MRI. , 2008, Handbook of experimental pharmacology.

[6]  N. Weissman,et al.  Multimodality imaging: opportunities and challenges. , 2013, JACC. Cardiovascular imaging.

[7]  R. Spaide,et al.  MULTIMODAL IMAGING FINDINGS AND MULTIMODAL VISION TESTING IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2015, Retina.

[8]  Jay S Duker,et al.  A review of optical coherence tomography angiography (OCTA) , 2015, International Journal of Retina and Vitreous.

[9]  R. Webb,et al.  Confocal scanning laser ophthalmoscope. , 1987, Applied optics.

[10]  H. Ameri,et al.  MULTIMODAL IMAGING OF GEOGRAPHIC AREAS OF RETINAL DARKENING. , 2015, Retinal cases & brief reports.

[11]  P. Artal,et al.  Adaptive-optics ultrahigh-resolution optical coherence tomography. , 2004, Optics letters.

[12]  Michael D. Ober,et al.  Ophthalmic fundus imaging: today and beyond. , 2004, American journal of ophthalmology.

[13]  A. Bird,et al.  FUNDUS AUTOFLUORESCENCE IMAGING: Review and Perspectives , 2008, Retina.

[14]  K. Park,et al.  Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography. , 2010, Investigative ophthalmology & visual science.

[15]  L A Yannuzzi,et al.  DIGITAL INDOCYANINE GREEN VIDEOANGIOGRAPHY AND CHOROIDAL NEOVASCULARIZATION , 1992, Retina.

[16]  Rajiv Chopra,et al.  Progress in Multimodality Imaging: Truly Simultaneous Ultrasound and Magnetic Resonance Imaging , 2007, IEEE Transactions on Medical Imaging.

[17]  K Bailey Freund,et al.  Optical Coherence Tomography Angiography of Shallow Irregular Pigment Epithelial Detachments In Pachychoroid Spectrum Disease. , 2015, American journal of ophthalmology.

[18]  J. Schuman,et al.  Optical coherence tomography. , 2000, Science.

[19]  A. Agarwal,et al.  MULTIMODAL IMAGING OF THE RETINA AND CHOROID IN SYSTEMIC AMYLOIDOSIS. , 2015, Retinal cases & brief reports.

[20]  K. Freund,et al.  EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY , 2016, Retina.

[21]  T. Hebert,et al.  Adaptive optics scanning laser ophthalmoscopy. , 2002, Optics express.

[22]  Thomas E. Yankeelov,et al.  Quantitative multimodality imaging in cancer research and therapy , 2014, Nature Reviews Clinical Oncology.

[23]  K. Freund,et al.  Pachychoroid Diseases of the Macula , 2014, Medical hypothesis, discovery & innovation ophthalmology journal.

[24]  Seung-Hee Baek,et al.  Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy , 2011, Acta ophthalmologica.

[25]  K. Freund,et al.  PACHYCHOROID NEOVASCULOPATHY , 2015, Retina.

[26]  Akitoshi Yoshida,et al.  Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study. , 2015, American journal of ophthalmology.

[27]  K Bailey Freund,et al.  PACHYCHOROID PIGMENT EPITHELIOPATHY , 2013, Retina.

[28]  Hisashi Yamada,et al.  Autosomal Dominant Occult Macular Dystrophy with an RP1L1 Mutation (R45W) , 2012, Optometry and vision science : official publication of the American Academy of Optometry.

[29]  Srinivas R Sadda,et al.  Retinal imaging in the twenty-first century: state of the art and future directions. , 2014, Ophthalmology.

[30]  C. Çevik,et al.  Multimodality imaging for pre-clinical assessment of Fabry's cardiomyopathy. , 2014, European heart journal cardiovascular Imaging.

[31]  M. Sonka,et al.  Retinal Imaging and Image Analysis , 2010, IEEE Reviews in Biomedical Engineering.

[32]  Marco Lupidi,et al.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION: A New Diagnostic Challenge , 2015, Retina.

[33]  Justis P Ehlers,et al.  Optical Coherence Tomography Angiography of Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy. , 2015, JAMA ophthalmology.

[34]  I. Chatziralli,et al.  Intravitreal Ranibizumab for Choroidal Neovascularization Secondary to Gyrate Atrophy in a Young Patient: A Multimodal Imaging Analysis , 2015, European journal of ophthalmology.